Lyka Labs Share Price
Lyka Labs Share Price Today
As of 5 Jul 2026, Lyka Labs share price is ₹72.39. The stock opened at ₹72.50, compared to its previous close of ₹72.33. During today's trading session, Lyka Labs share price moved in the range of ₹69.25 to ₹73.29, with an average price of ₹71.27 for the day. Looking at its last 52-week, the stock has touched a low of ₹44.10 and a high of ₹121.44. On the performance front, Lyka Labs share price has declined by 13.31% over the last six months and is down 37.38% on a year-on-year basis.
Lyka Labs Returns Calculator
Lyka Labs Shareholder Returns
Lyka Labs Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Lyka Labs Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹138.50 | ₹111.19 | ₹93.07 | ₹194.08 |
| Other Income | ₹2.23 | ₹1.45 | ₹3.40 | ₹2.09 |
| Total Revenue | ₹140.73 | ₹112.65 | ₹96.47 | ₹196.18 |
| Total Expenses | ₹129.60 | ₹113.17 | ₹102.25 | ₹130.41 |
| Profit Before Tax | ₹11.12 | -₹0.93 | -₹13.17 | ₹59.25 |
| Tax | ₹3.19 | ₹1.69 | -₹0.02 | ₹20.80 |
| Profit After Tax | ₹7.93 | -₹2.62 | -₹13.15 | ₹38.44 |
| EPS - Basic | ₹2.22 | -₹0.79 | -₹4.63 | ₹13.59 |
| EPS - Diluted | ₹2.22 | -₹0.79 | -₹4.63 | ₹13.59 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹11.12 | -₹0.93 | -₹13.17 | ₹59.25 |
| Income before WC changes | ₹19.59 | ₹17.09 | ₹18.61 | ₹101.18 |
| Change in Assets | -₹17.36 | -₹14.31 | ₹1.70 | -₹16.44 |
| Change in Liabilities | ₹2.71 | ₹0.51 | -₹11.56 | -₹4.58 |
| Change in WC | -₹14.65 | -₹13.80 | -₹9.86 | -₹21.01 |
| Cash flow from Operations | ₹1.90 | ₹1.77 | ₹8.95 | ₹79.25 |
| Cash flow from Investing | -₹11.80 | -₹9.49 | ₹7.35 | -₹6.17 |
| Cash flow from Financing | ₹5.29 | ₹1.95 | -₹21.64 | -₹63.18 |
| Total Cash Flow | -₹4.60 | -₹5.76 | -₹5.34 | ₹9.90 |
| Cash (Start of the year) | ₹5.95 | ₹11.71 | ₹17.05 | ₹7.15 |
| Cash (End of the year) | ₹1.34 | ₹5.95 | ₹11.71 | ₹17.05 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹108.77 | ₹106.07 | ₹107.32 | ₹133.42 |
| Current Assets | ₹67.43 | ₹50.65 | ₹44.20 | ₹52.20 |
| Total Assets | ₹176.21 | ₹156.72 | ₹151.52 | ₹185.61 |
| Current Liabilities | ₹46.63 | ₹37.64 | ₹32.60 | ₹99.35 |
| Net Current Asset | ₹20.80 | ₹13.01 | ₹11.61 | -₹47.15 |
| Non-Current Liabilities | ₹25.99 | ₹50.82 | ₹73.25 | ₹72.77 |
| Equity Capital | ₹103.58 | ₹68.27 | ₹45.67 | ₹13.49 |
| Total Equity & Liabilities | ₹176.21 | ₹156.72 | ₹151.52 | ₹185.61 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹134.70 | ₹106.40 | ₹80.59 | ₹164.35 |
| Other Income | ₹2.34 | ₹1.65 | ₹3.45 | ₹2.72 |
| Total Revenue | ₹137.04 | ₹108.04 | ₹84.04 | ₹167.07 |
| Total Expenses | ₹125.57 | ₹108.92 | ₹90.08 | ₹102.16 |
| Profit Before Tax | ₹11.47 | -₹0.93 | -₹13.21 | ₹60.24 |
| Tax | ₹3.25 | ₹1.34 | ₹0.08 | ₹20.34 |
| Profit After Tax | ₹8.23 | -₹2.27 | -₹13.29 | ₹39.90 |
| EPS - Basic | ₹2.28 | -₹0.72 | -₹4.65 | ₹13.90 |
| EPS - Diluted | ₹2.28 | -₹0.72 | -₹4.65 | ₹13.90 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹11.47 | -₹0.93 | -₹13.21 | ₹60.24 |
| Income before WC changes | ₹19.91 | ₹15.72 | ₹18.10 | ₹97.84 |
| Change in Assets | -₹16.25 | -₹12.62 | -₹2.61 | -₹14.78 |
| Change in Liabilities | ₹2.58 | ₹1.45 | -₹8.20 | -₹5.98 |
| Change in WC | -₹13.66 | -₹11.16 | -₹10.81 | -₹20.76 |
| Cash flow from Operations | ₹3.27 | ₹3.09 | ₹6.87 | ₹76.53 |
| Cash flow from Investing | -₹13.10 | -₹8.61 | ₹6.77 | -₹4.33 |
| Cash flow from Financing | ₹5.26 | ₹2.71 | -₹20.33 | -₹63.35 |
| Total Cash Flow | -₹4.57 | -₹2.81 | -₹6.69 | ₹8.85 |
| Cash (Start of the year) | ₹5.89 | ₹8.70 | ₹15.38 | ₹6.53 |
| Cash (End of the year) | ₹1.32 | ₹5.89 | ₹8.70 | ₹15.38 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹139.46 | ₹136.15 | ₹136.56 | ₹161.32 |
| Current Assets | ₹66.12 | ₹49.86 | ₹42.30 | ₹47.19 |
| Total Assets | ₹205.58 | ₹186.02 | ₹178.86 | ₹208.51 |
| Current Liabilities | ₹44.78 | ₹35.91 | ₹29.97 | ₹93.68 |
| Net Current Asset | ₹21.33 | ₹13.95 | ₹12.33 | -₹46.48 |
| Non-Current Liabilities | ₹25.85 | ₹50.78 | ₹72.46 | ₹70.40 |
| Equity Capital | ₹134.94 | ₹99.33 | ₹76.43 | ₹44.44 |
| Total Equity & Liabilities | ₹205.58 | ₹186.02 | ₹178.86 | ₹208.51 |
About Lyka Labs
Lyka Labs Limited is an India-based pharmaceutical company engaged in the development, manufacture and marketing of quality finished dosages. The Company manufactures pharmaceutical products such as Dry Powder, Liquid, Lyophilized Injections and External Preparations for several International Markets and the Domestic Market. The Company’s R&D is engaged in the development of new formulations and has developed several products in the categories, such as Injectables: Lyophilized Injection, Liquid Injections & Dry Powder Injections, and Topical Preparation: Ointment /Creams and Lotions. It offers formulations, such as emollient, anti-aging, cleansing lotion, hair care products, anti-dandruff shampoo, sunscreen, anti-acne, antioxidant tablets, antioxidants combination, proton pump inhibitor, antifungal, anti-malarial, antibacterial, corticosteroid hormones and cephalosporins. The Company's subsidiaries include Lyka BDR International Limited and Lyka Exports Limited.
Lyka Labs Financial Highlights
- Revenue: Lyka Labs reported revenue of ₹131.94 crore in FY26 vs ₹140.73 crore in FY25. It showed a decrease of 6.25% on a yearly basis.
- Operating Profit: Lyka Labs reported an operating loss of ₹11.78 crore in FY26 vs ₹11.12 crore in FY25. It showed a decrease of 205.94% on a year-on-year basis.
- Net Profit: Lyka Labs reported a net loss of ₹10.44 crore in FY26 vs ₹7.93 crore in FY25. It showed a decrease of 231.65% on a yearly basis.
Lyka Labs Quarterly Result Highlights
- Lyka Labs reported revenue of ₹28.64 crore in Mar 2026, compared with ₹31.89 crore in Dec 2025, representing a decrease of 10.19% on a quarter-on-quarter (QoQ) basis.
- Lyka Labs reported an operating loss of ₹8.59 crore in Mar 2026, compared with ₹0.16 crore in Dec 2025, representing a decrease of 5,268.75% on a quarter-on-quarter (QoQ) basis.
- Lyka Labs reported a loss of ₹8.07 crore in Mar 2026, compared with ₹0.15 crore in Dec 2025, reflecting a decrease of 5,280.00% on a QoQ basis.
- The earnings per share (EPS) of Lyka Labs stood at ₹2.22 during Mar 2026.
Similar Stocks
FAQs on Lyka Labs Share Price
What is Lyka Labs share price today?
Lyka Labs share price is ₹72.39 as on 03 Jul, 2026, 15:29 IST.
How has the Lyka Labs share price performed in the past?
In the last 1 year, Lyka Labs delivered a return of -37.38%. The Lyka Labs share price hit a high of ₹121.44 and low of ₹44.10.
How much is the Mutual Fund shareholding in Lyka Labs shares?
The Mutual Fund Shareholding in Lyka Labs was 0.01% at the end of Mar 2026.
What is the the 52-week high and low of Lyka Labs shares ?
The 52-week high and low of Lyka Labs share is ₹121.44 and ₹44.10 as of 03 Jul, 2026.
What is the market cap of Lyka Labs?
The market capitalisation of Lyka Labs is ₹260.30 Crores as on 03 Jul, 2026.
What are the stock symbols of Lyka Labs?
The stock symbol of Lyka Labs is LYKALABS on the NSE, 500259 on the BSE, and the ISIN is INE933A01014.
What was yesterday's closing price of Lyka Labs shares ?
Lyka Labs shares closed yesterday at ₹72.33 on NSE & ₹72.00 on BSE
How to buy Lyka Labs shares?
To buy Lyka Labs shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Lyka Labs shares on Holidays?
No, shares of Lyka Labs or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Lyka Labs shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Lyka Labs?
The PE and PB ratio of Lyka Labs is -24.91 and 2.8 respectively, as on 03 Jul, 2026, 15:29 IST.